The Interval to Biochemical Failure Is Prognostic for Metastasis, Prostate Cancer-Specific, and Overall Mortality Following Salvage Radiation Therapy for Prostate Cancer

被引：0
|
作者：
Johnson, S. [1 ]
Jackson, W. C. [1 ]
Foster, C. [1 ]
Li, D. [1 ]
Palapattu, G. S. [1 ]
Sandler, H. M. [2 ]
Feng, F. Y. [1 ]
Hamstra, D. A. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Cedars Sinai, Los Angeles, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2013年 / 87卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S396 / S396
页数：1
相关论文
共 50 条
  • [1] The Interval to Biochemical Failure Is Prognostic for Metastasis, Prostate Cancer-Specific Mortality, and Overall Mortality After Salvage Radiation Therapy for Prostate Cancer
    Johnson, Skyler
    Jackson, William
    Li, Darren
    Song, Yeohan
    Foster, Corey
    Foster, Ben
    Zhou, Jessica
    Vainshtein, Jeffrey
    Feng, Felix
    Hamstra, Daniel
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (03): : 554 - 561
  • [2] Interval to biochemical failure highly prognostic for distant metastasis and prostate cancer-specific mortality after radiotherapy
    Buyyounouski, Mark K.
    Hanlon, Alexandra L.
    Horwitz, Eric M.
    Pollack, Alan
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (01): : 59 - 66
  • [3] Interval to biochemical failure is prognostic for distant metastases after salvage radiation therapy for prostate cancer
    Zaorsky, Nicholas George
    Li, Tianyu
    Turaka, Aruna
    Chen, David Y. T.
    Horwitz, Eric M.
    Buyyounouski, Mark K.
    [J]. JOURNAL OF RADIATION ONCOLOGY, 2016, 5 (01) : 79 - 85
  • [4] Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical Failure
    Jackson, William C.
    Suresh, Krithika
    Tumati, Vasu
    Dess, Robert T.
    Soni, Payal D.
    Zhao, Shuang G.
    Zumsteg, Zachary S.
    Hannan, Raquibul
    Hollenbeck, Brent K.
    George, Arvin
    Kaffenberger, Samuel D.
    Salami, Simpa S.
    Hearn, Jason W. D.
    Morgan, Todd M.
    Mehra, Rohit
    Schipper, Matthew
    Feng, Felix Y.
    Desai, Neil B.
    Spratt, Daniel E.
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2018, 1 (04): : 276 - 282
  • [5] Prostate Cancer-Specific Mortality Following Salvage Post-Prostatectomy Radiation Therapy: A Competition Between Age and Time to Biochemical Failure
    Jackson, W. C.
    Suresh, K.
    Tumati, V.
    Dess, R. T.
    Soni, P. D.
    Zhao, S. G.
    Zumsteg, Z. S.
    Hannan, R.
    Hollenbeck, B.
    George, A.
    Kaffenberger, S.
    Salami, S.
    Hearn, J. W. D.
    Jolly, S.
    Morgan, T. M.
    Mehra, R.
    Schipper, M.
    Feng, F. Y.
    Desai, N. B.
    Spratt, D. E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E120 - E121
  • [6] Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure
    D'Amico, AV
    Moul, JW
    Carroll, PR
    Cote, K
    Sun, L
    Lubeck, D
    Renshaw, AA
    Loffredo, M
    Chen, MH
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (07) : 509 - 515
  • [7] Biochemical failure in prostate cancer following radiation therapy
    Makarewicz, Roman
    Reszke, Joanna
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2006, 10 (04): : 152 - 155
  • [8] Prostate Cancer-Specific Mortality and Survival Outcomes for Salvage Radiation Therapy After Radical Prostatectomy
    Agrawal, S.
    Stephenson, A. J.
    Michalski, J.
    Efstathiou, J. A.
    Pisansky, T. M.
    Feng, F.
    Hamstra, D. A.
    Koontz, B. F.
    Liauw, S.
    Abramowitz, M. C.
    Pollack, A.
    Anscher, M. S.
    Moghanaki, D.
    Den, R. B.
    Stephans, K. L.
    Gao, T.
    Kattan, M.
    Tendulkar, R. D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S101 - S101
  • [9] Predictors of prostate cancer-specific mortality following radical prostatectomy or radiation therapy.
    Zhou, P
    Chen, MH
    McLeod, D
    Carroll, PR
    Moul, JW
    D'Amico, AV
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 389S - 389S
  • [10] Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure
    Stewart, AJ
    Scher, HI
    Chen, MH
    McLeod, DG
    Carroll, PR
    Moul, JW
    D'Amico, AV
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6556 - 6560
12345